Armata Pharmaceuticals (ARMP) Shares Outstanding (Diluted Average): 2013-2018
Historic Shares Outstanding (Diluted Average) for Armata Pharmaceuticals (ARMP) over the last 5 years, with Sep 2018 value amounting to $4.7 million.
- Armata Pharmaceuticals' Shares Outstanding (Diluted Average) fell 47.57% to $4.7 million in Q3 2018 from the same period last year, while for Sep 2018 it was $4.7 million, marking a year-over-year decrease of 47.57%. This contributed to the annual value of $6.6 million for FY2017, which is 568.21% up from last year.
- Per Armata Pharmaceuticals' latest filing, its Shares Outstanding (Diluted Average) stood at $4.7 million for Q3 2018, which was down 0.00% from $4.7 million recorded in Q2 2018.
- In the past 5 years, Armata Pharmaceuticals' Shares Outstanding (Diluted Average) registered a high of $8.9 million during Q3 2017, and its lowest value of $876,806 during Q2 2016.
- Over the past 3 years, Armata Pharmaceuticals' median Shares Outstanding (Diluted Average) value was $4.7 million (recorded in 2018), while the average stood at $4.3 million.
- In the last 5 years, Armata Pharmaceuticals' Shares Outstanding (Diluted Average) crashed by 94.18% in 2014 and then skyrocketed by 698.07% in 2017.
- Armata Pharmaceuticals' Shares Outstanding (Diluted Average) (Quarterly) stood at $5.9 million in 2014, then declined by 8.08% to $5.4 million in 2015, then crashed by 81.82% to $983,846 in 2016, then skyrocketed by 568.21% to $6.6 million in 2017, then tumbled by 47.57% to $4.7 million in 2018.
- Its Shares Outstanding (Diluted Average) was $4.7 million in Q3 2018, compared to $4.7 million in Q2 2018 and $6.6 million in Q4 2017.